Hologic plans to acquire Finland-based molecular diagnostic company Mobidiag for $785m to take advantage of the fast-growing acute care market.
Mobidiag develops and markets polymerase chain reaction (PCR) tests for acute conditions, including gastrointestinal and respiratory infections, as well as...